Activate Immunotherapy Terminates Financing Agreement
Activate Immunotherapy today announced that the financing agreement with NovaRx has been terminated by mutual agreement. Activate Immunotherapy will be dissolved and wound up. CONTACT: Dr. Stella M. Sung, Chief Business Officer Activate Immunotherapy ssung …